Pilot study on the additive effects of berberine and oral type 2 diabetes agents for patients with suboptimal glycemic control

Código QR

Pilot study on the additive effects of berberine and oral type 2 diabetes agents for patients with suboptimal glycemic control

Francesco Di Pierro,1 Nicola Villanova,2 Federica Agostini,2 Rebecca Marzocchi,2 Valentina Soverini,2 Giulio Marchesini21Scientific Department, Velleja Research, Milano, 2Diseases of Metabolism, S Orsola Malpighi Hospital, Bologna, ItalyBackground: Suboptimal glycemic control is a common situation i...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Di Pierro F, Villanova N, Agostini F, Marzocchi R, Soverini V, Marchesini G
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2012
Materias:	Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/0f81c6f0d75840f58855d9da75664e32
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Glycemic control and anti-osteopathic effect of propolis in diabetic rats
por: Al-Hariri M,&nbsp;Gamal Eldin T, et al.
Publicado: (2011)

Sotagliflozin improves glycemic control in nonobese diabetes-prone mice with type 1 diabetes
por: Powell DR, et al.
Publicado: (2015)

Clinical role of a fixed combination of standardized Berberis aristata and Silybum marianum extracts in diabetic and hypercholesterolemic patients intolerant to statins
por: Di Pierro F, et al.
Publicado: (2015)

Effects of zinc and multimineral vitamin supplementation on glycemic and lipid control in adult diabetes
por: Priyanka Gunasekara, et al.
Publicado: (2011)

Myocardial perfusion imaging for evaluation of suspected ischemia and its relationship with glycemic control in South African subjects with diabetes mellitus
por: Shmendi A, et al.
Publicado: (2014)

Critical appraisal of the safety and efficacy of insulin detemir in glycemic control and cardiovascular risk management in diabetics
por: Jean-Pierre Le Floch
Publicado: (2010)

Repaglinide/metformin fixed-dose combination to improve glycemic control in patients with type 2 diabetes: an update
por: Robert G Moses
Publicado: (2010)

Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes
por: Michael A Via, et al.
Publicado: (2010)

Leukocyte peroxidase and leptin: an associated link of glycemic tolerance and bronchial asthma?
por: Sergio Parco
Publicado: (2010)

Glycemic control after initiating basal insulin therapy in patients with type 2 diabetes: a primary care database analysis
por: Kostev K, et al.
Publicado: (2015)

Relationship between oxidized low-density lipoprotein antibodies and obesity in different glycemic situations
por: Babakr AT, et al.
Publicado: (2014)

Level of sustained glycemic control and associated factors among patients with diabetes mellitus in Ethiopia: a hospital-based cross-sectional study
por: Abebe SM, et al.
Publicado: (2015)

Potential glycemic overtreatment in patients ≥75 years with type 2 diabetes mellitus and renal disease: experience from the observational OREDIA study
por: Penfornis A, et al.
Publicado: (2015)

Exenatide once weekly: sustained improvement in glycemic control and cardiometabolic measures through 3 years
por: MacConell L, et al.
Publicado: (2013)

Improving glycemic and cholesterol control through an integrated approach incorporating colesevelam &ndash; a clinical perspective
por: Ronald B Goldberg
Publicado: (2009)

Assessing the impact of a new delivery method of insulin on glycemic control using a novel trial design
por: Thomas Strack, et al.
Publicado: (2009)

TRC210258, a novel TGR5 agonist, reduces glycemic and dyslipidemic cardiovascular risk in animal models of diabesity
por: Zambad SP, et al.
Publicado: (2013)

Withdrawal of sulfonylureas from patients with type 2 diabetes receiving long-term sulfonylurea and insulin combination therapy results in deterioration of glycemic control: a randomized controlled trial
por: Srivanichakorn W, et al.
Publicado: (2015)

The role of insulin glulisine to improve glycemic control in children with diabetes mellitus
por: Carter J, et al.
Publicado: (2010)

Randomized, double-blind, placebo-controlled, clinical study on the effect of Diabetinol® on glycemic control of subjects with impaired fasting glucose
por: Evans M, et al.
Publicado: (2015)

Preliminary study about the possible glycemic clinical advantage in using a fixed combination of Berberis aristata and Silybum marianum standardized extracts versus only Berberis aristata in patients with type 2 diabetes
por: Di Pierro F, et al.
Publicado: (2013)

Leukocyte peroxidase and leptin: an associated link of glycemic tolerance and bronchial asthma?
por: Parco S
Publicado: (2010)

Alogliptin: a new addition to the class of DPP-4 inhibitors
por: Radha Andukuri, et al.
Publicado: (2009)

Potential role of linagliptin as an oral once-daily treatment for patients with type 2 diabetes
por: Hoimark L, et al.
Publicado: (2012)

Standardized Glycemic Management versus Conventional Glycemic Management and Postoperative Outcomes in Type 2 Diabetes Patients Undergoing Elective Surgery
por: Vongsumran N, et al.
Publicado: (2020)

Glycemic control and diabetes complications among diabetes mellitus patients attending at University of Gondar Hospital, Northwest Ethiopia
por: Fasil A, et al.
Publicado: (2018)

An Evaluation of a Nutraceutical with Berberine, Curcumin, Inositol, Banaba and Chromium Picolinate in Patients with Fasting Dysglycemia
por: Derosa G, et al.
Publicado: (2020)

Potent antiatherosclerotic effects of alogliptin in addition to its potent antidiabetic effects
por: Kapoor S
Publicado: (2012)

Real-world glycemic outcomes in patients with type 2 diabetes initiating exenatide once weekly and liraglutide once daily: a retrospective cohort study
por: Saunders WB, et al.
Publicado: (2016)

Effect of orally administered dipterinyl calcium pentahydrate on oral glucose tolerance in diet-induced obese mice
por: Fuchs D, et al.
Publicado: (2012)

Cardiovascular Risk Prediction, Glycemic Control, and Determinants in Diabetic and Hypertensive Patients in Massawa Hospital, Eritrea: Cross-Sectional Study on 600 Subjects
por: Tesfai B, et al.
Publicado: (2021)

Tackling obesity: new therapeutic agents for assisted weight loss
por: JG Karam, et al.
Publicado: (2010)

Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes
por: Via MA
Publicado: (2010)

Diabetes and depression in Lebanon and association with glycemic control: a cross-sectional study
por: Ahmadieh H, et al.
Publicado: (2018)

Racial Variation in the Relationship of Glycemic Control with Fracture Risk in Elderly Patients with Diabetes
por: Figaro MK, et al.
Publicado: (2020)

Effect of berberine on the HPA-axis pathway and skeletal muscle GLUT4 in type 2 diabetes mellitus rats
por: Mi J, et al.
Publicado: (2019)

Glycemic Control, Diabetes Complications and Their Determinants Among Ambulatory Diabetes Mellitus Patients in Southwest Ethiopia: A Prospective Cross-Sectional Study
por: YimamAhmed M, et al.
Publicado: (2020)

The prevalence and determinants of poor glycemic control among adults with type 2 diabetes mellitus in Saudi Arabia
por: Alzaheb RA, et al.
Publicado: (2018)

Lycopene Improves the Metformin Effects on Glycemic Control and Decreases Biomarkers of Glycoxidative Stress in Diabetic Rats
por: Figueiredo ID, et al.
Publicado: (2020)

Role of glycemic control on hospital-related outcomes in patients with diabetes mellitus undergoing renal transplantation
por: Lamos EM, et al.
Publicado: (2017)